Since the discovery of the potential role of RUNX3 in the initiation and the progression of gastric cancer, RUNX3 has been found to be involved in the development of a variety of cancers, including colon, liver, lung and breast cancer [38]–[41]. Here, RUNX3 is linked to breast carcinoma.